Company Profile

TEJNAKSH HEALTHCARE LTD.

NSE : NABSE : 539428ISIN CODE : INE030T01019Industry : Hospital & Healthcare ServicesHouse : Private
BSE70.650.75 (+1.07 % )
PREV CLOSE (Rs.) 69.90
OPEN PRICE (Rs.) 72.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3847
TODAY'S LOW / HIGH (Rs.)67.00 72.85
52 WK LOW / HIGH (Rs.) 22.95 85
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 2.72334
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 17.27
ROCE (%) 16.58
Incorporation Year : 2008

Management Info :

- Chairman Ashish Vishwas Rawandale - Managing Director

Registered Office :

Address : Lion Tarachandbapa Hospital,Lion Tarachandbapa Hospital Marg,Sion (West),
Mumbai,
Maharashtra-400022

Phone : 022 2404 4983 /2404 4984

Email : NA

Website : www.tejnaksh.com

Registrar's Details : Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE
NEWS More
05Apr04-05-2021$ Announcement_Regulation_30_Appointment Of Dr. Ashish Rawandale, Managing Director Of The Company On The Board Of Bureau Of Indian Standards. Announcement_Regulation_30_
With reference to captioned subject, we are immense pleasure to inform you that the Dr. Ashish Rawandale, Managing Director of the Company has been appointed on the Board of Bureau of Indian Standards.
With reference to captioned subject, we are immense pleasure to..
30Mar03-30-2021$ Announcement Under Regulation 30 (LODR) _ Commercial Availability Of Tejnaksh Urology Simulators Announcement Under Regulati
With reference to above subject, we are pleased to inform that Tejnaksh Healthcare Limited has ready to use simulators which are available commercially. The simulators developed and patented by the Innovation Division of Tejnaksh Healthcare Limited, headed by Dr. Ashish Rawandale- Patil, are now available in the market:
With reference to above subject, we are pleased to inform that..
19Jan01-19-2021$Tejnaksh Healthcare submits certificate Tejnaksh Healthcare submits

In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, Tejnaksh Healthcare has informed that it has enclosed certificate received from Cameo Corporate Services (RTA) for the Quarter ended December 31, 2020.

The above information is a part of company’s filings submitted to BSE.

In accordance with Regulation 74 (5) of the SEBI (Depositories..
07Jan01-07-2021$ Reply To The Clarification Sought On Price Movement In The Shares Of The Company. Reply To The Clarification
Reply to the Clarification sought on Price Movement in the shares of the Company.
Reply to the Clarification sought on Price Movement in the shar..
06Jan01-06-2021$ Clarification sought from Tejnaksh Healthcare Ltd Clarification sought from T
The Exchange has sought clarification from Tejnaksh Healthcare Ltd on January 6, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
The Exchange has sought clarification from Tejnaksh Healthcare..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit6.0619.24
Gross Profit 6.77 26.61
Operating Profit 9.5740.42
Net Sales 24.99111.38
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Metropolis Health. (BSE)
 2483.20 (3.67%)
M.Cap ( in Cr)
12693.33
Thyrocare Tech. (BSE)
 1040.20 (3.10%)
M.Cap ( in Cr)
5500.00
Apollo Hospital Ent. (BSE)
 3133.30 (0.61%)
M.Cap ( in Cr)
45052.05
Aster DM Healthcare (BSE)
 148.10 (8.90%)
M.Cap ( in Cr)
7397.79
Dr Lal Pathlabs (BSE)
 3139.20 (0.33%)
M.Cap ( in Cr)
26163.62
Shareholding Pattern More
PROMOTERS 73.84 %
NON-INSTITUTION 25.75 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes